Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...
The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet ...
The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...
The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.
In the last year, many Merck & Co., Inc. ( NYSE:MRK ) insiders sold a substantial stake in the company which may ...
Aptiv is one of a number of multinationals gathering in Shanghai to test the pulse of China's smart manufacturing market, ...
A majority of people who are eligible for lung cancer screening responded that they hadn't heard of the test or hadn't discussed it with a clinician.
Merck has recently inaugurated its new 290 million-euro biosafety testing facility in Rockville, Maryland, USA with an aim to ...
While crouching behind a boulder on the Bridger Mountains near Bozeman, Montana, Michel Louge watched in awe as the ...
The deal with China’s Chimagen Biosciences is the latest example of pharma interest in exploring the potential of “T cell engagers” in autoimmune disease.